Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata from this FDA Warning Letter, Anderson Compounding Pharmacy, Inc. received a regulatory notice on January 13, 2020, regarding drug compounding operations. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product authority, though the specific issuing office is not identified in this metadata. To understand the particular compliance issues cited, the complete warning letter would need to be reviewed.